HOME >> BIOLOGY >> NEWS
Vertex Researchers Report Three-Dimensional Atomic Structure Of JNK3 Enzyme; Report In Structure

Vertex researchers have solved the three-dimensional atomic structure of the JNK3 enzyme, a research advance that may pave the way for new drugs to treat epilepsy and stroke. The discovery, which represents the first known structure of JNK3, will be published in the August 15, 1998 issue of the journal Structure.

JNK3 belongs to the MAP Kinase family of enzymes, a group of proteins that help to transmit signals from the surface of cells to the nucleus, allowing cells to respond to their environment. Pharmaceutical industry interest in JNK3 stems from animal studies that implicate JNK3 in neurological diseases such as epilepsy. Genomic research has shown that mice bred to be deficient in JNK3 show reduced susceptibility to seizure and neuronal cell death.

Vertex's has an established track record of applying structural information to genomic discoveries as part of an effort to discover new drugs against innovative targets. Vertex employs an interdisciplinary approach that integrates biophysics, biology and chemistry towards the efficient design and development of novel pharmaceuticals.


'"/>

Contact: Michael Partridge
partridge@vpharm.com
(617) 577-6108
Vertex Pharmaceuticals
14-Aug-1998


Page: 1

Related biology news :

1. Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertexs Investigational IMPDH Inhibitor VX-497
2. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
3. Vertex Pharmaceuticals/Yale Research Team Uses Gene Knockout Mice To Establish Role Of Caspase-9 In Neuronal Cell Death Pathway
4. Vertex Pharmaceuticals Researchers Report Three-Dimensional Structure Of Hepatitis C Helicase Enzyme; Report In Structure
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Researchers identify protein promoting vascular tumor growth
8. Researchers devise potent new tools to curb ivory poaching
9. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
10. Researchers ID chlorophyll-regulating gene
11. Researchers develop fast track way to discover how cells are regulated

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2019)... ... May 30, 2019 , ... Enso Discoveries Chief Executive Officer, Patrick Farley, is ... as a way to express his gratitude and respect for those who have served ... Enso Discoveries — presented a check for $1,000 to the Green Beret ...
(Date:5/24/2019)... (PRWEB) , ... May 24, 2019 , ... The newest ... and is now available on the company’s global website. , Crystallography Times is a ... crystal X-ray diffraction. It serves the X-ray analysis community by presenting the latest news ...
(Date:5/23/2019)... SAN FRANCISCO (PRWEB) , ... May 23, 2019 ... ... Intelligent Virtual Agents for sales and service organizations, today announced its ... report identifies Inference Solutions as the intelligent virtual agent (IVA) market share leader, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized ... provides Object exclusive ownership and commercialization rights to a full spectrum of botulinum ...
Breaking Biology Technology:
Cached News: